友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。
期刊名
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
BIOORG MED CHEM LETT
ISSN / eISSN
0960-894X / 1464-3405
目标和范围
Bioorganic & Medicinal Chemistry Letters presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.
研究方向
有机化学
药物化学
CiteScore
5.70
查看趋势图
CiteScore 学科排名
| 类别 | 分区 | 排名 |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science | Q2 | #61/183 |
| Pharmacology, Toxicology and Pharmaceutics - Organic Chemistry | Q2 | #74/211 |
| Pharmacology, Toxicology and Pharmaceutics - Clinical Biochemistry | Q2 | #50/117 |
| Pharmacology, Toxicology and Pharmaceutics - Drug Discovery | Q2 | #74/157 |
| Pharmacology, Toxicology and Pharmaceutics - Biochemistry | Q2 | #219/438 |
| Pharmacology, Toxicology and Pharmaceutics - Molecular Biology | Q3 | #227/410 |
| Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine | Q3 | #99/178 |
Web of Science 核心收藏夹
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| 类别 (Journal Citation Reports 2024) | 分区 |
|---|---|
| CHEMISTRY, MEDICINAL | Q3 |
| CHEMISTRY, ORGANIC | Q2 |
H-index
133
出版国家或地区
ENGLAND
出版商
Elsevier Ltd
出版周期
Semimonthly
出版年份
1991
年文章数
288
Open Access
NO
通讯方式
PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB
认证评论
2022.1.15. revision - Revision on January 15, 2022.
2022.2.14. accepted - Accepted on February 14, 2022.
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started